BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND DCTN1, DAP-150, 1639, ENSG00000204843, Q14203, P135, DP-150 AND Treatment
6 results:

  • 1. Safety, Tolerability, and Antitumor Activity of Zipalertinib Among Patients With Non-Small-Cell lung cancer Harboring Epidermal Growth Factor Receptor Exon 20 Insertions.
    Piotrowska Z; Tan DS; Smit EF; Spira AI; Soo RA; Nguyen D; Lee VH; Yang JC; Velcheti V; Wrangle JM; Socinski MA; Koczywas M; Janik JE; Jones J; Yu HA
    J Clin Oncol; 2023 Sep; 41(26):4218-4225. PubMed ID: 37384848
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. ALK-rearranged Mesenchymal Neoplasms: A Report of 9 cases Further Expanding the Clinicopathologic Spectrum of Emerging Kinase Fusion Positive Group of Tumors.
    Dermawan JK; DiNapoli SE; Mullaney KA; Sukhadia P; Agaram NP; Dickson BC; Antonescu CR
    Genes Chromosomes Cancer; 2023 Feb; 62(2):75-84. PubMed ID: 36125853
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Effectiveness of alectinib and osimertinib in a brain metastasized lung adenocarcinoma patient with concurrent EGFR mutations and dctn1-ALK fusion.
    Yin Q; Guo T; Zhou Y; Sun L; Meng M; Ma L; Wang X
    Thorac Cancer; 2022 Feb; 13(4):637-642. PubMed ID: 34964276
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Tobacco smoking induces changes in true DNA methylation, hydroxymethylation and gene expression in bronchoalveolar lavage cells.
    Ringh MV; Hagemann-Jensen M; Needhamsen M; Kular L; Breeze CE; Sjöholm LK; Slavec L; Kullberg S; Wahlström J; Grunewald J; Brynedal B; Liu Y; Almgren M; Jagodic M; Öckinger J; Ekström TJ
    EBioMedicine; 2019 Aug; 46():290-304. PubMed ID: 31303497
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Anticancer activity of green synthesised AgNPs from
    Chen Z; Ye X; Qingkui G; Wenliang Q; Wen Z; Ning W; Min Z
    IET Nanobiotechnol; 2019 Apr; 13(2):178-182. PubMed ID: 31051448
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. SWOG S0722: phase II study of mTOR inhibitor everolimus (RAD001) in advanced malignant pleural mesothelioma (MPM).
    Ou SH; Moon J; Garland LL; Mack PC; Testa JR; Tsao AS; Wozniak AJ; Gandara DR
    J Thorac Oncol; 2015 Feb; 10(2):387-91. PubMed ID: 25611229
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.